Correlation Between Cue Biopharma and Corbus Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Cue Biopharma and Corbus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cue Biopharma and Corbus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cue Biopharma and Corbus Pharmaceuticals Holding, you can compare the effects of market volatilities on Cue Biopharma and Corbus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cue Biopharma with a short position of Corbus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cue Biopharma and Corbus Pharmaceuticals.
Diversification Opportunities for Cue Biopharma and Corbus Pharmaceuticals
-0.64 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Cue and Corbus is -0.64. Overlapping area represents the amount of risk that can be diversified away by holding Cue Biopharma and Corbus Pharmaceuticals Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Corbus Pharmaceuticals and Cue Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cue Biopharma are associated (or correlated) with Corbus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Corbus Pharmaceuticals has no effect on the direction of Cue Biopharma i.e., Cue Biopharma and Corbus Pharmaceuticals go up and down completely randomly.
Pair Corralation between Cue Biopharma and Corbus Pharmaceuticals
Considering the 90-day investment horizon Cue Biopharma is expected to under-perform the Corbus Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Cue Biopharma is 2.08 times less risky than Corbus Pharmaceuticals. The stock trades about -0.02 of its potential returns per unit of risk. The Corbus Pharmaceuticals Holding is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 686.00 in Corbus Pharmaceuticals Holding on August 26, 2024 and sell it today you would earn a total of 1,061 from holding Corbus Pharmaceuticals Holding or generate 154.66% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cue Biopharma vs. Corbus Pharmaceuticals Holding
Performance |
| Timeline |
| Cue Biopharma |
| Corbus Pharmaceuticals |
Cue Biopharma and Corbus Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cue Biopharma and Corbus Pharmaceuticals
The main advantage of trading using opposite Cue Biopharma and Corbus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cue Biopharma position performs unexpectedly, Corbus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Corbus Pharmaceuticals will offset losses from the drop in Corbus Pharmaceuticals' long position.| Cue Biopharma vs. Coya Therapeutics, Common | Cue Biopharma vs. Lantern Pharma | Cue Biopharma vs. Fennec Pharmaceuticals | Cue Biopharma vs. Eliem Therapeutics |
| Corbus Pharmaceuticals vs. Trevi Therapeutics | Corbus Pharmaceuticals vs. Cue Biopharma | Corbus Pharmaceuticals vs. AN2 Therapeutics | Corbus Pharmaceuticals vs. Bioatla |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Complementary Tools
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |